References
- Prashanth R, Tagore S, Vinaya G. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27.
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:https://doi.org/10.1002/ijc.29210
- Al-Wadei MH, Al-Wadei HA, Schuller HM. Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7. Mol Cancer Res. 2012;10(2):239–49. doi:https://doi.org/10.1158/1541-7786.MCR-11-0332
- Réjiba S, Bigand C, Parmentier C, Hajri A . Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies. Neoplasia. 2009; 11(7):637–50. doi:https://doi.org/10.1593/neo.81686
- Abdullah JM, Ahmad F, Ahmad KAK, Ghazali MM, Jaafar H, Ideris A, Ali AM, Omar AR, Yusoff K, Lila MAM, et al. Molecular genetic analysis of bax and cyclin d1 genes in patients with malignant glioma. Neurol Res. 2007; 29(3):239–42. doi:https://doi.org/10.1179/016164107X158965
- Lei D, Jiaqi C, Wen L, Hongjian C, Xianhui X, Hongshun A, Min Y, Jie L, Qinghua C. The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci. 2020;21(6):1960.
- Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94 (12):1313–26. doi:https://doi.org/10.1007/s00109-016-1475-3
- Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol. 2010;20(7):427–34. doi:https://doi.org/10.1016/j.tcb.2010.03.004
- Engeland K. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ. 2018;25(1):114–32. doi:https://doi.org/10.1038/cdd.2017.172
- Nina-Naomi K, Frank L, Juping Y. The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy. Cancers (Basel). 2019; 11(9):1220.
- Stivala LA, Cazzalini O, Prosperi E. The cyclin-dependent kinase inhibitor p21CDKN1A as a target of anti-cancer drugs. Curr Cancer Drug Targets. 2012;12(2):85–96. doi:https://doi.org/10.2174/156800912799095126
- Kreis N-N, Sanhaji M, Rieger MA, Louwen F, Yuan J. p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene. 2014;33(50):5716–28. doi:https://doi.org/10.1038/onc.2013.518
- Greenwell M, Rahman PKSM. Rahman medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res. 2015; 6(10):4103–12. doi:https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12
- Arpita R, Shruti A, Navneeta B. A review on medicinal plants against cancer. Plant Sci Agric. 2017;2(1):008. Res
- Esmaeili S, Irani M, Zehan HM, Keramatian B, Harandi ZT, Hamzeloo-Moghadam M. Cytotoxic activity of some ethnic medicinal plants from southwest of Iran. Res J Pharmacogn. 2016; 3(1):43–7.
- Baradaran RV, Rakhshandeh H, Raucci F, Buono B, Shirazinia R, Samzadeh Kermani A. Anti-inflammatory and anti-oxidant activity of Portulaca oleracea extract on LPS-induced rat lung injury. Molecules. 2019; 24:E139. doi:https://doi.org/10.3390/molecules24010139
- Boskabady MH, Hashemzehi M, Khazdair MR, Askari VR. Hydro-ethanolic extract of Portulaca oleracea affects beta-adrenoceptors of Guinea pig tracheal smooth muscle. Iran J Pharm Res. 2016; 15(4):867–74.
- Chen T, Wang J, Li Y, Shen J, Zhao T, Zhang H. Sulfated modification and cytotoxicity of Portulaca oleracea L. polysaccharides. Glycoconj J. 2010; 27(6):635– 42. doi:https://doi.org/10.1007/s10719-010-9307-0
- Askari VR, Rezaee SA, Abnous K, Iranshahi M, Boskabady MH. The influence of hydro-ethanolic extract of Portulaca oleracea L. on Th 1/Th 2 balance in isolated human lymphocytes. J Ethnopharmacol. 2016; 194:1112–21. doi:https://doi.org/10.1016/j.jep.2016.10.082
- Azarifar Z, Mortazavi M, Farhadian R, Parvari S, Mohammadi R. A. Cytotoxicity effects of aqueous extract of Purtulaca oleracea on HeLa cell line. Pharm Sci. 2015;21(1):41–5. doi:https://doi.org/10.15171/PS.2015.15
- Manojlović NT, Mašković PZ, Vasiljević PJ, Jelić RM, Jusković MŽ, Miroslav S, Leka M, Marija R. HPLC Analysis, antimicrobial and antioxidant activities of Daphne cneorum L. Hemijska Industrija. 2012; 66(5):709.
- Wang W, Li N, Luo M, Zu Y, Efferth T. Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules. 2012; 17 (3):2704–13. doi:https://doi.org/10.3390/molecules17032704
- Shokrzadeh M, Parvaresh A, Shahani S, Habibi E, Zalzar Z. Cytotoxic effects of Lagenaria siceraria Standl extract on cancer cell lin. JMUMS. 2013; 22(97):225–30.
- Stoddart MJ. Cell viability assays: introduction. In Mamm cell viability. 2011;740:1–6. Humana Press. doi:https://doi.org/10.1007/978-1-61779-108-6_1 PMID: 21468961.
- Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol. 2004; 281:301–11. doi:https://doi.org/10.1385/1-59259-811-0:301
- Badmus JA, Ekpo OE, Hussein AA, Meyer M, Hiss DC. Corrigendum to “Antiproliferative and Apoptosis Induction Potential of the Methanolic Leaf Extract of Holarrhena floribunda (G. Don))”. Evid Based Complement Alternat Med. 2020;2020:4319146. doi:https://doi.org/10.1155/2020/4319146
- Modi S, Kir D, Banerjee S, Saluja A. Control of apoptosis in treatment and biology of pancreatic cancer. J Cell Biochem. 2016;117(2):279–88. Feb; doi:https://doi.org/10.1002/jcb.25284
- Abbassi R, Algül H, Palliative chemotherapy in pancreatic cancer-treatment sequences. Transl Gastroenterol Hepatol. 2019;4:56. doi:https://doi.org/10.21037/tgh.2019.06.09
- Arpita R, Shruti A, Navneeta B. A review on medicinal plants against cancer. Plant Sci Agric Res. 2017;2(1):008.
- Ramezani M, Rahmani F, Dehestani A. Comparison between the effects of potassium phosphite and chitosan on changes in the concentration of Cucurbitacin E and on antibacterial property of Cucumis sativus. BMC Complement Altern Med. 2017;17(1):295. doi:https://doi.org/10.1186/s12906-017-1808-y
- Ramezani M, Hasani M, Ramezani F, Abdolmaleki MK. Cucurbitacins: A focus on Cucurbitacin E as a natural product and their biological activities. Pharm Sci. 2020; 27 (1):1–13. doi:https://doi.org/10.34172/PS.2020.66
- Vishal C, Vigya M, Dwivedi SV, Sharma KD. Purslane (Portulaca oleracea L.): An underutilized wonder plant with potential pharmacological value. Pharma Innov J. 2019; 8(6):236–46.
- Uddin MK, Juraimi AS, Hossain MS, Nahar MAU, Ali ME, Rahman MM. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. ScientWorld J. 2014;2014:951019. doi:https://doi.org/10.1155/2014/951019
- Azarifar Z, Piri K, Maghsoudi H, Abbasi Malati Z, Mohammadi Roushandeh, A . Cytotoxic Effects of aqueous extract of Portulaca oleracea on oral cancer cell line. IJBC. 2018;10(1):20–4.
- Mulla SK, Swamy P. Anticancer activity of ethanol and polyphenol extracts of Portulaca quadrifida linn. On human colon cancer cell lines. Int J Pharm Biol Sci. 2012;3(3):488–98.
- Gartel AL . The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res. 2005;29(11):1237–8. doi:https://doi.org/10.1016/j.leukres.2005.04.023
- Roshanravan N, Asgharian P, Dariushnejad H, Mesri Alamdari N, Mansoori B, Mohammadi A, Alipour S, Barati M, Ghavami A, Ghorbanzadeh V, et al. Eryngium Billardieri induces apoptosis via Bax gene expression in pancreatic cancer cells. Adv Pharm Bull. 2018; 8(4):667–74. doi:https://doi.org/10.15171/apb.2018.075
- Guo YZ, Li PQ, Xiao QY, Wei G, Hong Z, Hai LX. Portulacerebroside A induces apoptosis via activation of the mitochondrial death pathway in human liver cancer HCCLM3 cells. Phytochemistry Lett. 2014;7:77–84[Mismatch.
- Zhao R, Zhang T, Ma B, Li X. Baoling Ma 3, Xing Li. Antitumor activity of Portulaca Oleracea L. polysaccharide on HeLa cells through inducing TLR4/NF-κB signaling. Nutr Cancer. 2017;69(1):131–9. doi:https://doi.org/10.1080/01635581.2017.1248294
- Zhao R, Gao X, Cai Y, Shao X, Jia G, Huang Y, Qin X, Wang J, Zheng X. Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo. Carbohydr Polym. 2013;96(2):376–83. doi:https://doi.org/10.1016/j.carbpol.2013.04.023
- Huan S, Guo T, Guang Z, Ningxin Z. Purification and characterization of an antitumor polysaccharide from Portulaca oleracea L. Carbohydr Polym. 2013;2(2):395–400.